Trials / Sponsors / Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults Wi Sarcoma,Soft Tissue | Phase 3 | 2024-06-28 |
| Completed | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 Breast Cancer, Head and Neck Cancer, Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2017-02-09 |